Application of the immune-correcting therapy in complex treatment of surgical forms of erysipelas

Keywords: surgical forms of erysipelas; іmmunomodulating therapy; іmmunostimulating therapy.

Abstract

Objective. To investigate the efficacy of immunomodulating and immunostimulating therapy in complex treatment of patients, suffering surgical forms of erysipelas.Materials and methods. Retrospectively and prospectively there were analyzed 284 patients’ hospital charts, who were treated stationary in Centre of Purulent-Septic Surgery of Zaporizhzhya Municipal Hospital №3 in 2016 - 2021 yrs.

Results. In patients, suffering erythematous form of erysipelas, disorders in cellular and humoral chains of immunity were not revealed. The immune disorders formula in bullous form was following: CD3+ 1, CD4+ 1, CD8-1, CD16-2, CD22-1, what witnessed about misbalance of the immune system Degree I, of possibly compensatory character; in a phlegmonous one - CD3+ 1, CD4-1, CD8-1, CD16-2, CD22-1, witnessing actuality of the immune disorders of Degree І, while in the necrotic one - CD3-2, CD4-2, CD8-1, CD16-2, CD22-1, trusting presence of the immune disorders of Degree ІІI.

Conclusion. Administration of erbisol-extra and laferon for destructive forms of erysipelas is pathogenetically substantiated and may be applied in complex treatment of the disease.

Author Biographies

S. D. Shapoval, Zaporizhzhya Medical Academy of Post-Graduate Education

Shapoval Serhii D., MD, DSci(Med), Professor.
Director of the Institute of sepsis
Zaporizhia Medical Academy of Postgraduate Education
Wintera blvd., Zaporizhia, Ukraine, 69096,
+38 (061) 213-15-42,
shapoval.s.d@gmail.com
http://orcid.org/0000-0001-8516-9494

L. A. Vasylevska, Zaporizhzhya Medical Academy of Post-Graduate Education

Vasylevska L.A., MD, PhD(Med), Associate professor
Associate professo r of outpatient, purulent-septic surgery and ultrasound diagnostics,
Zaporizhia Medical Academy of Postgraduate Education
Wintera blvd., Zaporizhia, Ukraine, 69096,
+38 (061) 213-15-42,
larisavasilevskaya1970@gmail.com
http://orcid.org/0000-0002-0607-5279

References

Brazhnik EA, Ostroushko AP. Erysipelas in surgical practice. Scientific Review. Medical sciences. 2016;(4):14-17. Russian.

Gopatsa GV, Ermakova LA. Erysipelas: current state of the problem Scientific Almanac. 2016;(1-2):364-6. Russian. doi: 10.17117/na.2016.01.02.364.

Zemskov AM, Zemskov VM, Chereshnev VA, Reshetnikov SS, Galimzyanov HM, Zemskova VA. Moscоw: Triada-X; 2011. 288 p. Russian. ISBN 978-5-8249-0162-7.

Nikolov VV, Ospanbekova NK, Denefil EV, Pokryshko EV, Volchev VI, Guleva DV, Marina SS. Immune and neuroregulatory disorders in erysipelas. Clinical immunology. Allergology. Infectology. 2015;(1): 43-48. Russian.

Bashkina OA, Samotrueva MA, Azhikova AK, Paknnova LR. Neuroimmunoendocrine regulation of the skin functioning. Medical Immunology (Russia). 2019;21(5):807-20. Russian. doi: 10.15789/1563-0625-2019-5-807-820.

Cherkasov VL, Matkovsky VS, Ivanov AI. Rozha. Leningrad: Medicine; 1986. 200 p. Russian.

Shapoval SD, Vasilevska LA. Variety of diagnosed microorganisms in patients with erysipelas. Art of Medicine.2021; (2):140-3. Ukrainian. DOI: 10.21802/artm.2021.2.18.140.

Bruun T, Oppegaard O, Hufthammer KO, Langeland N, Skrede S. Early Response in Cellulitis: A Prospective Study of Dynamics and Predictors. Clin Infect Dis. 2016 Oct 15;63(8):1034-41. doi: 10.1093/cid/ciw463. Epub 2016 Jul 11. PMID: 27402819; PMCID: PMC5036916.

Yang SS, Chandran NS, Huang JX, Tan KB, Aw DC. A Fatal Case of "Bullous Erysipelas-like" Pseudomonas Vasculitis. Indian J Dermatol. 2016 Jan-Feb;61(1):120. doi: 10.4103/0019-5154.174095. PMID: 26955132; PMCID: PMC4763643.

Published
2021-10-28
How to Cite
Shapoval, S. D., Vorontsova, L. L., & Vasylevska, L. A. (2021). Application of the immune-correcting therapy in complex treatment of surgical forms of erysipelas. Klinicheskaia Khirurgiia, 88(5-6), 53-55. https://doi.org/10.26779/2522-1396.2021.5-6.53
Section
General Problems of Surgery